Chad Messer
Stock Analyst at Lake Street
(0.45)
# 3,993
Out of 4,876 analysts
24
Total ratings
29.17%
Success rate
-27.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BOLT Bolt Biotherapeutics | Initiates: Buy | $80 | $5.61 | +1,326.02% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.19 | +683.70% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $8.77 | +162.26% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.84 | +932.61% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $0.99 | +11,373.43% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $12.54 | +298.72% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $33.16 | +44.75% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $43.67 | -31.30% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $29.03 | +72.24% | 1 | Jun 17, 2021 | |
| CRMD CorMedix | Maintains: Buy | $31 → $29 | $12.50 | +132.00% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.66 | +275.94% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $39.80 | +116.08% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $2.57 | +2,818.29% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $11.64 | +278.01% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $17.11 | +870.19% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.65 | +393.15% | 1 | May 5, 2020 |
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $80
Current: $5.61
Upside: +1,326.02%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.19
Upside: +683.70%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $8.77
Upside: +162.26%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.84
Upside: +932.61%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $0.99
Upside: +11,373.43%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $12.54
Upside: +298.72%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $33.16
Upside: +44.75%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $43.67
Upside: -31.30%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $29.03
Upside: +72.24%
CorMedix
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $12.50
Upside: +132.00%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.66
Upside: +275.94%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $39.80
Upside: +116.08%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $2.57
Upside: +2,818.29%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $11.64
Upside: +278.01%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $17.11
Upside: +870.19%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.65
Upside: +393.15%